The global apheresis market is anticipated to grow at a considerable CAGR of 8.4% during the forecast period (2023-2030). The market’s growth is attributed to the demand for specialized biospecimens across the globe. Plasmapheresis, plateletpheresis, and leukapheresis procedure involve the separation of components of the blood. Plasmapheresis involves the removal and reinfusion of plasma, the liquid component of blood, that is used for the treatment of various disorders and to manufacture plasma-derived therapies. Plateletpheresis involves the collection of platelets, that are cell fragments critical for blood clotting and are used to support cancer patients undergoing chemotherapy and those with thrombocytosis. Additionally, leukapheresis involves the selective removal of white blood cells and is used in the treatment of leukemia and other disorders where excessive white blood cells are present, in addition for the collection of leukopaks for research and immunotherapy.
Browse the full report description of “Apheresis Market Size, Share & Trends Analysis Report by Product (Apheresis Disposables, Apheresis Devices), by Procedure (Automated blood collection, Therapeutic Apheresis), and by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis)Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/apheresis-market
The increasing demand for specialized biospecimens such as leukopaks in the field of medical research and therapeutic development is one of the main driving factors. Concentrated white blood cells, or leukopaks, are vital for examining immunological responses, in carrying out clinical studies, and creating novel therapeutics. Leukopak collection is the facility's primary focus in response to the rising demand for high-quality biospecimens. Consequently, the market players are coming up with new products to cater the demand for blood donation facility. For instance, in September 2023, Sanguine Biosciences launched a blood donation facility has opened in Los Angeles, California. The facility specializes in obtaining leukopaks, or concentrated white blood cell biospecimens, from members of Sanguine's Patient Community network. The research tools support initiatives for developing innovative therapies from conception through production.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product
o By Procedure
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Cerus Corp., Crown Bioscience, Inc., Fresenius SE & Co. KGaA, Haemonetics, Kaneka Corp., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Apheresis Market Report Segment
By Product
By Procedure
By Application
Global Apheresis Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/apheresis-market